<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="iso-abbrev">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="doi">10.5812/ircmj</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Iranian Red Crescent Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">2074-1804</issn><issn pub-type="epub">2074-1812</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24396571</article-id><article-id pub-id-type="pmc">3871739</article-id><article-id pub-id-type="doi">10.5812/ircmj.11540</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of Oral Tiazinidine Effects on [intraoperative] Hemodynamic Responses During Direct Laryngoscopy Under General Anesthesia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tabari</surname><given-names>Masoomeh</given-names></name><xref ref-type="aff" rid="aff18694">1</xref><xref ref-type="corresp" rid="cor18695">*</xref></contrib><contrib contrib-type="author"><name><surname>Alipour</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff18694">1</xref></contrib><contrib contrib-type="author"><name><surname>Esalati</surname><given-names>Hamideh</given-names></name><xref ref-type="aff" rid="aff18694">1</xref></contrib></contrib-group><aff id="aff18694"><label>1</label>Department of Anesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran</aff><author-notes><corresp id="cor18695"><label>*</label>Corresponding author: Masoomeh Tabari, Department of Anesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran, Tel/Fax: +98-5118424685, E-mail: <email>Tabarim@mums.ac.ir</email>.</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>7</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2013</year></pub-date><volume>15</volume><issue>7</issue><fpage>541</fpage><lpage>546</lpage><history><date date-type="received"><day>13</day><month>4</month><year>2013</year></date><date date-type="rev-recd"><day>23</day><month>5</month><year>2013</year></date><date date-type="accepted"><day>31</day><month>5</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013, Iranian Red Crescent Medical Journal</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Direct laryngoscopy and tracheal intubation can result in blood pressure and heart rate increase which in turn may lead to myocardial ischemia, cerebral hemorrhage, and even death in susceptible patients. Tizanidine is &#x003b1;<sub>2</sub>-receptor agonists that suppresses central sympathetic system.</p></sec><sec><title>Objectives</title><p>This study evaluates the effects of oral Tizanidine on hemodynamic responses during operations and aims to determine the appropriate Propofol dosage to maintain anesthesia under BIS monitoring.</p></sec><sec><title>Materials and Methods</title><p>A double-blind clinical trial has been performed on 70 candidates for elective abdominal surgery undergoing general anesthesia in Educational Hospital of Ghaem, Mashhad, Iran. 35 randomly selected patients (the case group) were given 4 mg of oral Tizanidine 90 minutes before the induction of anesthesia whereas the remaining subjects (the control group) were given placebo. Blood pressure and heart rate before and after induction of anesthesia, and after intubation and extubation, existence of postoperative shivering, and the needed Propofol dosage were measured and recorded. Data analysis was done with T-test and Chi-squared test, using SPSS software version 16.</p></sec><sec><title>Results</title><p>Variations of blood pressure and heart rate after anesthesia induction, intubation and extubation were less in Tizanidine group generally. Postoperative shivering was reported in 28.6% and 11.4% of patients in control and case group respectively. Average propofol needed dose for anesthesia maintenance in case group was 25% less than the needed amount in the control group.</p></sec><sec><title>Conclusions</title><p>Using oral Tizanidine as a premedication, yielded stability in blood pressure and heart rate during surgery and decreased required Propofol. Considering its short duration of action, Tizanidine use as a premedication is recommended for sedation and stabilization of hemodynamic responses during the operations.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Tizanidine</kwd><kwd>Hemodynamic</kwd><kwd>Propofol</kwd><kwd>Premedication</kwd></kwd-group></article-meta></front><body><sec id="sec21541"><title>1. Background</title><p>Increased blood pressure and heart rate due to laryngoscopy and tracheal intubation may result in myocardial ischemia, cerebral hemorrhage and death during the operations in susceptible patients. Minimizing persistent and severe alterations in heart rate and systemic blood pressure is critical. Increased heart rate raises the myocardial oxygen demand and shortens the diastolic period, which is responsible for maintaining coronary blood flow (<xref ref-type="bibr" rid="A11540R1">1</xref>). Myocardial ischemia may occur as a consequence of increased heart rate and blood pressure caused by sympathetic nervous system response during direct laryngoscopy and intubation. Usual recommendations suggest maintaining heart rate and blood pressure at 20% of the basal value (<xref ref-type="bibr" rid="A11540R1">1</xref>, <xref ref-type="bibr" rid="A11540R2">2</xref>). &#x003b1;<sub>2</sub>-Receptor agonists decrease the catecholamine&#x02019;s release; thus, they can diminish the hyper dynamic status which renders the patients prone to ischemia. Mild diminution in heart rate preserves the oxygen supply to demand ratio in an appropriate range. Hemodynamic stabilization, during and after the operations, is the most important mechanism by which the &#x003b1;<sub>2</sub>-receptor agonists reduce peri-operative ischemia (<xref ref-type="bibr" rid="A11540R3">3</xref>).</p><p>Until now, various drugs have been applied as premedication to reduce severe hemodynamic alteration during anesthesia induction and laryngoscopy. Tizanidine is a &#x003b1;<sub>2</sub>-receptor agonist derived from Clonidine which possesses sedative, anxiolytic and analgesic properties. Its major side-effects include heart rate and blood pressure decrease which are observed less frequently when compared to the side effects of the remaining drugs in this class, such as Clonidine (<xref ref-type="bibr" rid="A11540R4">4</xref>). &#x003b1;<sub>2</sub>-agonists have sedative, anxiolytic and analgesic effects and serve to decrease autonomic nervous system responses, i.e., increase in blood pressure and heart rate and the catecholamines release, caused by preoperative anxiousness, laryngoscopy, tracheal intubation and stimulation due to the surgery (<xref ref-type="bibr" rid="A11540R5">5</xref>); They are effective in postoperative shivering control as well (<xref ref-type="bibr" rid="A11540R6">6</xref>, <xref ref-type="bibr" rid="A11540R7">7</xref>). Administration of Tizanidine may result in hemodynamic stability and decrease the myocardial ischemia and postoperative shivering.</p></sec><sec id="sec21542"><title>2. Objectives</title><p>This study attempts to survey the effects of the oral premedication Tizanidine on intraoperative hemodynamic responses and postoperative shivering. It also investigates the required Propofol dosage for anesthesia maintenance of anesthesia.</p></sec><sec id="sec21543"><title>3. Materials and Methods</title><p>This double-blind clinical trial surveyed 70 patients aged between 20 to 60 years with the American Society of Anesthesiologists classification (ASA) class 1 and 2 candidates for elective abdominal surgery undergoing general anesthesia at Ghaem Educational, Research and Treatment Center of Mashhad University of Medical Sciences (MUMS). Prior to the surgery all the patients were informed about the investigation and the testimonials were obtained. The patients with positive history of hypertension, Diabetes Mellitus, cardiac disease, renal failure, cirrhosis, neurological disease, or recent consumption of drugs were omitted from the study, as well as the smokers, opiate addicts and the patients with bradycardia (heart rates below 60 beats/min). The study was finally approved in session of 28th may 2011 regional ethics committee, Mashhad University of medical sciences, with code of 89869.</p><p>Randomly, the patients were divided into two groups. 90 minutes before the surgery one 4 mg Tizanidine tablet (product of the Swedish company, Novartis<sup>&#x000ae;</sup>) was prescribed to case group, while the other group was treated with placebo. All of the patients underwent basic monitoring including noninvasive observation of blood pressure, electrocardiography, arterial saturation of oxygen (<italic>S</italic><sub><italic>a</italic></sub><italic>O</italic><sub><italic>2</italic></sub>), heart rate, and bispectral index (BIS) monitoring as they entered the operating room.</p><p>Initially, 0.04 mg/kg of Midazolam and 3-4 mcg/kg of Fentanyl were administered as premedication to all patients. Anesthesia induction was performed with 2mg/kg Propofol and 0.6 mg/kg Atracurium. The anesthetics used for maintenance for all patients were 50-150 mcg/kg/h Propofol (which was infused by the pump) alongside with the composition of <italic>N</italic><sub><italic>2</italic></sub><italic>O</italic> 50% and 50%, as well as 0.02-0.05 mcg/kg/h of Fentanyl, and 0.2 mg/kg of Atracurium per each 20 minutes. Furthermore, Ringer solution was infused in all patients before anesthesia induction. In both groups, the patients with airway insertion difficulties and those for whom the process of laryngoscopy and intubation was prolonged to more than 20 minutes were excluded from the study. BIS was maintained at the level of 40-60 in all patients, thorough out the operation. Provided that BIS fell in the target range, in the cases of severe (more than 20% basic level) increase and decrease in blood pressure either 5-50 mcg/min of nitroglycerin and 5 mg of ephedrine or 500 cc of Ringer solution was infused respectively. Also, 0.5 mg of Atropine was prescribed for cases with heart rates below 40 beats/min.</p><p>All of the patients underwent ventilation with tidal volume (TV) and Flow (F) values of 8-10 cc/kg and 10-12/min, respectively. End tidal <italic>CO</italic><sub><italic>2</italic></sub> (ET<italic> CO</italic><sub><italic>2</italic></sub>) was sustained in a limit of 30-40 mmHg. The patient&#x02019;s blood pressure and heart rate were monitored and recorded before induction of anesthesia, at two minutes after anesthesia, at one and five minutes after intubation, and after extubation of the airways. Eventually, at the end of the surgery, relaxing effect of anesthetics on skeletal muscles was neutralized using 0.04 mg/kg of Neostigmine and 0.02 mg/kg of Atropine. The amount of consumed Propofol, duration of anesthesia from induction of anesthesia to extubation of the airways, the postoperative shivering presence from patients&#x02019; extubation to his/her discharge from the recovery was recorded in a specifically designed checklist. All the observations and measurements were done by one of the authors or under supervision of her. She was completely trained for instruments usage. We used automatic blood pressure device (non-invasive blood pressure) for measuring Blood pressure (mmHg) and pulse oximetry monitor for heart rate (beats/min). We also used biseptical index monitor for anesthesia depth (0-100). All the instruments were calibrated.</p><p>Statistical analysis of data was performed by student&#x02019;s T-test and Chi-squared test via SPSS (Version 16.0). This study aimed to compare instability seen in hemodynamic properties between tizanidine received (case) and non-tizanidine received (control) patients. Regarding the fact that some of the patients would show increase and some other would manifest with decrease in the aforementioned variables, using the Mean in whole sample size do not seem to be appropriate for comparison. So we separated the patients into two groups for statistical analysis: 1- Group with variable reduction and 2- Group with variable increase.</p></sec><sec id="sec21544"><title>4. Results</title><p>70 patients (65 males, 5 females) with the mean age of 36.77 &#x000b1; 11.13 years were enrolled the study in case (33 males, 2 females) and control (32 males, 3 females) groups. The mean age of the patients was reported 36.57 &#x000b1; 11.31 years in cases and 36.97 &#x000b1; 11.11 years in controls. The difference between the two groups was not significant. (P = 0.882) Most of the participants were in ASA class I. Only 9 patients (13%) belonged to class II. (5 case patients and 4 controls; P = 0.721). The mean duration of anesthesia was 110.64 &#x000b1; 44.63 min (35 to 240) in all the patients. Cases (113.57 &#x000b1; 48.83) and controls (107.71 &#x000b1; 40.52) were similar in terms of anesthesia duration (P = 0.587).</p><p>As demonstrated in <xref ref-type="table" rid="tbl5951">Table 1</xref>, there was no significant difference of basic and demographic data between the two groups. (P &#x0003e; 0.05) The systolic, diastolic and mean arterial blood pressure together with heart rate average before anesthesia induction was not significantly different between control and case group before the induction of anesthesia (at the start point). <xref ref-type="table" rid="tbl5952">Table 2</xref> displays Average percentages of variations in mean arterial pressure (MAP), systolic and diastolic blood pressure, and heart rate in different times. In a 2 minute interval after the anesthesia induction, hemodynamic instability was more prominent in control group. This finding could be seen in both the patients with decrease and those with increase in hemodynamic properties. For example, although the mean diastolic blood pressure changes from the start point was not significantly different between the groups, (-18.28 &#x000b1; 12.92 mmHg in cases and -24.68 &#x000b1; 18.32 mmHg for control patients, P = 0.096) the standard deviation was bigger in control patients. In order to achieve a better comparison we considered the changes regarding the decrease or increase in diastolic blood pressure. We found more prominent changes in both the decrease and increase groups among the control patients. (P = 0.006 and P = 0.025 respectively, <xref ref-type="table" rid="tbl5952">Table 2</xref>). </p><table-wrap id="tbl5951" orientation="portrait" position="float"><label>Table 1.</label><caption><title>General Demographics and Hemodynamic Parameters Before Anesthesia Induction in the Both Groups </title></caption><table frame="hsides" rules="groups"><thead><tr><th style="vertical-align: middle; text-align: left;" rowspan="1" colspan="1">
</th><th style="vertical-align: middle; text-align: left;" rowspan="1" colspan="1">Control</th><th style="vertical-align: middle; text-align: left;" rowspan="1" colspan="1">Case</th><th style="vertical-align: middle; text-align: left;" rowspan="1" colspan="1"><italic>P</italic> Value</th></tr></thead><tbody><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Sex</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Male</td><td style="vertical-align: middle;" rowspan="1" colspan="1">3</td><td style="vertical-align: middle;" rowspan="1" colspan="1">2</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.643</td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Female</td><td style="vertical-align: middle;" rowspan="1" colspan="1">32</td><td style="vertical-align: middle;" rowspan="1" colspan="1">33</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">36.97 &#x000b1; 11.11</td><td style="vertical-align: middle;" rowspan="1" colspan="1">36.57 &#x000b1; 11.31</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.882</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>BMI (kg/m2)A</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">25.92 &#x000b1; 4.9191.4 &#x000b1; 92.25</td><td style="vertical-align: middle;" rowspan="1" colspan="1">32/4 &#x000b1; 27.26</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.753</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>ASA class</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">I</td><td style="vertical-align: middle;" rowspan="1" colspan="1">31</td><td style="vertical-align: middle;" rowspan="1" colspan="1">30</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.721</td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">II</td><td style="vertical-align: middle;" rowspan="1" colspan="1">4</td><td style="vertical-align: middle;" rowspan="1" colspan="1">5</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Anesthesia duration </bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">107.71 &#x000b1; 40.52</td><td style="vertical-align: middle;" rowspan="1" colspan="1">113.57 &#x000b1; 48.83</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.587</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Systolic blood pressure</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">128.63 &#x000b1; 17.61</td><td style="vertical-align: middle;" rowspan="1" colspan="1">124.63 &#x000b1; 13.81</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.294</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Diastolic blood pressure</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">84.29 &#x000b1; 10.98</td><td style="vertical-align: middle;" rowspan="1" colspan="1">80.83 &#x000b1; 10.30</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.179</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Mean arterial pressure</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">97.74 &#x000b1; 13.25</td><td style="vertical-align: middle;" rowspan="1" colspan="1">93.77 &#x000b1; 11.71</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.193</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Heart rate</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">92.71 &#x000b1; 69.16</td><td style="vertical-align: middle;" rowspan="1" colspan="1">87.77 &#x000b1; 11.51</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.154</td></tr></tbody></table></table-wrap><table-wrap id="tbl5952" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Systolic Blood Pressure/Mean Arterial Pressure/ Heart Rate Variation in the Two Groups Based on the Increase and Decrease From the Basal Level During the Course of Time </title></caption><table frame="hsides" rules="groups"><thead><tr style="border-bottom:solid thin;"><th style="vertical-align: middle;text-align: left;" rowspan="1" colspan="1"/><th style="vertical-align: middle;text-align: left;" colspan="3" rowspan="1">Group with variablee reduction</th><th style="vertical-align: middle;text-align: left;" colspan="3" rowspan="1">Group with variable increase</th></tr><tr><th style="vertical-align: middle;text-align: left;" rowspan="1" colspan="1">
</th><th style="vertical-align: top;text-align: left;" rowspan="1" colspan="1">Control Group</th><th style="vertical-align: top;text-align: left;" rowspan="1" colspan="1">Case group</th><th style="vertical-align: top;text-align: left;" rowspan="1" colspan="1"><italic>P</italic> Value</th><th style="vertical-align: top;text-align: left;" rowspan="1" colspan="1">Control Group</th><th style="vertical-align: top;text-align: left;" rowspan="1" colspan="1">Case Group</th><th style="vertical-align: top;text-align: left;" rowspan="1" colspan="1"><italic>P</italic> Value</th></tr></thead><tbody><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>2 minutes after anesthesia induction</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Systolic blood pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-26.05 &#x000b1; 11.80</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-15.81 &#x000b1; 8.31</td><td style="vertical-align: middle;" rowspan="1" colspan="1">&#x0003c; 0.001 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td><td style="vertical-align: middle;" rowspan="1" colspan="1">6.41 &#x000b1; 2.22</td><td style="vertical-align: middle;" rowspan="1" colspan="1">4.30 &#x000b1; 0</td><td style="vertical-align: top;" rowspan="1" colspan="1">
<sup><xref ref-type="table-fn" rid="fn3973">b</xref></sup>
</td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Mean arterial pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-27.92 &#x000b1; 13.64</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-16.31 &#x000b1; 10.04</td><td style="vertical-align: middle;" rowspan="1" colspan="1">&#x0003c; 0.001 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td><td style="vertical-align: middle;" rowspan="1" colspan="1">7.36 &#x000b1; 8.71</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.77 &#x000b1; 1.33</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.321</td></tr><tr><td style="padding-left: 20pt;vertical-align: middle;" rowspan="1" colspan="1">Diastolic blood pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-29.32 &#x000b1; 13.62</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-20.25 &#x000b1; 11.64</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.006 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td><td style="vertical-align: middle;" rowspan="1" colspan="1">11.22 &#x000b1; 3.50 </td><td style="vertical-align: middle;" rowspan="1" colspan="1">2.76 &#x000b1; 3.54</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.025 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Heart rate</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-16.27 &#x000b1; 10.33</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-12.79 &#x000b1; 6.52</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.177</td><td style="vertical-align: middle;" rowspan="1" colspan="1">8.29 &#x000b1; 9.55</td><td style="vertical-align: middle;" rowspan="1" colspan="1">9.98 &#x000b1; 5.97</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.751</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>1 Minutes after intubation</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Systolic blood pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-18/26 &#x000b1; 9/61</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-11.54 &#x000b1; 7.38</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.008 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td><td style="vertical-align: middle;" rowspan="1" colspan="1">13.64 &#x000b1; 11.94</td><td style="vertical-align: middle;" rowspan="1" colspan="1">9.15 &#x000b1; 10.95</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.424</td></tr><tr><td style="padding-left: 20pt;vertical-align: middle;" rowspan="1" colspan="1">Mean arterial pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-18/07 &#x000b1; 9/74</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-14.14 &#x000b1; 10.57</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.194</td><td style="vertical-align: middle;" rowspan="1" colspan="1">14.02 &#x000b1; 12.52</td><td style="vertical-align: middle;" rowspan="1" colspan="1">6.94 &#x000b1; 5.31</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.106</td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Diastolic blood pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-16.87 &#x000b1; 12.25</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-13.33 &#x000b1; 8.68</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.273</td><td style="vertical-align: middle;" rowspan="1" colspan="1">18.63 &#x000b1; 10.54</td><td style="vertical-align: middle;" rowspan="1" colspan="1">9.08 &#x000b1; 8.81</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.022 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Heart rate</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-14.02 &#x000b1; 7.51</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-74.12 &#x000b1; 8.30</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.591</td><td style="vertical-align: middle;" rowspan="1" colspan="1">15.44 &#x000b1; 16.85</td><td style="vertical-align: middle;" rowspan="1" colspan="1">8.05 &#x000b1; 7.65</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.184</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>5 Minutes after intubation</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Systolic blood Pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-21.79 &#x000b1; 9.27</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-14.55 &#x000b1; 8.37</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.004 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td><td style="vertical-align: middle;" rowspan="1" colspan="1">8.47 &#x000b1; 7.54</td><td style="vertical-align: middle;" rowspan="1" colspan="1">3.34 &#x000b1; 3.42</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.169</td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Mean arterial pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-18.06 &#x000b1; 11.69</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-05.16 &#x000b1; 7.40</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.458</td><td style="vertical-align: middle;" rowspan="1" colspan="1">15.17 &#x000b1; 16.22</td><td style="vertical-align: middle;" rowspan="1" colspan="1">2.76 &#x000b1; 2.68</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.038 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Diastolic blood pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-18.91 &#x000b1; 11.67</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-16.39 &#x000b1; 9.36</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.398</td><td style="vertical-align: middle;" rowspan="1" colspan="1">16.49 &#x000b1; 9.66</td><td style="vertical-align: middle;" rowspan="1" colspan="1">4.01 &#x000b1; 2.66</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.008 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Heart rate</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-20.14 &#x000b1; 10.10</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-12.95 &#x000b1; 9.59</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.008 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td><td style="vertical-align: middle;" rowspan="1" colspan="1">10.96 &#x000b1; 9.33</td><td style="vertical-align: middle;" rowspan="1" colspan="1">9.21 &#x000b1; 5.90</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.683</td></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>1 Minutes after extubation</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;vertical-align: middle;" rowspan="1" colspan="1">Systolic blood pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-7.13 &#x000b1; 5.10</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-9.04 &#x000b1; 7.84</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.468</td><td style="vertical-align: middle;" rowspan="1" colspan="1">19.52 &#x000b1; 14.54</td><td style="vertical-align: middle;" rowspan="1" colspan="1">10.61 &#x000b1; 8.55</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.017 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Mean arterial pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-8/41 &#x000b1; 4.44</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-10/78 &#x000b1; 6/32</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.282</td><td style="vertical-align: middle;" rowspan="1" colspan="1">22/36 &#x000b1; 15/63</td><td style="vertical-align: middle;" rowspan="1" colspan="1">12/35 &#x000b1; 12/18</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.020 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Diastolic blood pressure</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-9/86 &#x000b1; 7/32</td><td style="vertical-align: middle;" rowspan="1" colspan="1">11/78 &#x000b1; 5/66</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.430</td><td style="vertical-align: middle;" rowspan="1" colspan="1">23/73 &#x000b1; 16/90</td><td style="vertical-align: middle;" rowspan="1" colspan="1">17/75 &#x000b1; 19/66</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.308</td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Heart rate</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-22/29 &#x000b1; 10/03</td><td style="vertical-align: middle;" rowspan="1" colspan="1">-14/16 &#x000b1; 9/21</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.021 <sup><xref ref-type="table-fn" rid="fn3972">a</xref></sup></td><td style="vertical-align: middle;" rowspan="1" colspan="1">17/67 &#x000b1; 14/61</td><td style="vertical-align: middle;" rowspan="1" colspan="1">12/90 &#x000b1; 9/48</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.245</td></tr></tbody></table><table-wrap-foot><fn id="fn3972"><p><sup>a</sup>Statistically Significant (P &#x0003c; 0.05)</p></fn><fn id="fn3973"><p><sup>b</sup>Cannot be compared due to Subject Scarcity</p></fn></table-wrap-foot></table-wrap><p>The findings are summarized with details in <xref ref-type="table" rid="tbl5952">Table 2</xref> for systolic and mean blood pressure, and also heart rate. For all the variables, instability is obviously less pronounced in patients who received Tizanidine in. One minute after the intubation, the systolic blood pressure showed 11.54 &#x000b1; 7.38 mmHg decrease mmHg in case group which is obviously less than the decrease seen in controls (18.26 &#x000b1; 9.61). (P = 0.008) In patients with blood pressure increase, the changes were also more minute in cases (9.15 &#x000b1; 10.95 mmHg) compared to controls (13.64 &#x000b1; 11.49 mmHg). The difference was not statistically significant. (P = 0.424) The situation was similar for diastolic blood pressure, mean arterial blood pressure, and heart rate changes (<xref ref-type="table" rid="tbl5952">Table 2</xref>). </p><p>In patients with increased mean arterial blood pressure, the changes were more severe in controls (15.17 &#x000b1; 16.22 mmHg) in comparison to cases following a 5 minute interval after intubation (2.76 &#x000b1; 2.68 mmHg). The difference was significant. (P = 0.038) In the patients with decrease in hemodynamic properties, the mean arterial blood pressure was found to have -18.06 &#x000b1; 11.69 mmHg decreases in controls which is obviously more severe than the measured -16.05 &#x000b1; 7.40 seen in cases. When if the difference was not statistically significant. (P = 0.458) The conditions were similar for systolic, diastolic blood pressure, and heart rate (<xref ref-type="table" rid="tbl5952">Table 2</xref>). In a 1 minute interval after the extubation, the instability was clearly less intense in patients who received tizanidine. In patients with Heart rate increase, the changes were less severe in cases (12.90 &#x000b1; 9.48 beats/s) in comparison to controls (17.67 &#x000b1; 14.61 beats/s). The difference was not statistically significant. (P = 0.245) The Heart rate changes showed -14.16 &#x000b1; 9.21 beats/s decreases in cases which is significantly less than -22.29 &#x000b1; 10.03 beats/s seen in controls. (P = 0.021) The findings were similar for systolic, diastolic and mean arterial blood pressure. (<xref ref-type="table" rid="tbl5952">Table 2</xref>)The frequency distribution for incidence of postoperative shivering in control and case group is shown in <xref ref-type="table" rid="tbl5953">Table 3</xref>; indicating that 10 subjects (28.6%) in control group and 4 subjects (11.4%) in the case group had postoperative shivering that is considerable, with no statistically significant difference (P = 0.073). Moreover, the required dosage of Propofol for anesthesia maintenance was measured 68.77 &#x000b1; 16.04 &#x000b5;g/kg/min in case patients against the reported 90.06 &#x000b1; 17.37 &#x000b5;g/kg/min in controls. As demonstrated in <xref ref-type="table" rid="tbl5953">Table 3</xref>, the required dosage of Propofol for anesthesia maintenance is significantly higher in the control group patients (P &#x0003c; 0.001). </p><table-wrap id="tbl5953" orientation="portrait" position="float"><label>Table 3.</label><caption><title>The Incidence of Postoperative Shivering (Chi- square test) and the Mean Required Propofol Dosage (g/kg/min) to Maintain Anesthesia </title></caption><table frame="hsides" rules="groups"><thead><tr><th style="vertical-align: middle; text-align: left;" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Control Group</th><th align="left" rowspan="1" colspan="1">Case Group</th><th align="left" rowspan="1" colspan="1"><italic>P</italic> Value</th></tr></thead><tbody><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Postoperative shivering</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">Yes</td><td style="vertical-align: middle;" rowspan="1" colspan="1">10 (28.6%)</td><td style="vertical-align: middle;" rowspan="1" colspan="1">4 (11.4%)</td><td style="vertical-align: middle;" rowspan="1" colspan="1">0.073</td></tr><tr><td style="padding-left: 20pt; vertical-align: middle;" rowspan="1" colspan="1">No</td><td style="vertical-align: middle;" rowspan="1" colspan="1">25 (71.4%)</td><td style="vertical-align: middle;" rowspan="1" colspan="1">31 (88.6%)</td><td style="vertical-align: middle;" rowspan="1" colspan="1"/></tr><tr><td style="vertical-align: middle;" rowspan="1" colspan="1">
<bold>Required propofol dosage</bold>
</td><td style="vertical-align: middle;" rowspan="1" colspan="1">90.06 &#x000b1;17.37</td><td style="vertical-align: middle;" rowspan="1" colspan="1">68.77 &#x000b1; 16.04</td><td style="vertical-align: middle;" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr></tbody></table></table-wrap></sec><sec id="sec21545"><title>5. Discussion</title><p>Study of Takenaka et al. suggested that Clonidine can decreases severe alterations in blood pressure and heart rate during the surgeries (<xref ref-type="bibr" rid="A11540R8">8</xref>). The idea is supported by other similar studies (<xref ref-type="bibr" rid="A11540R9">9</xref>-<xref ref-type="bibr" rid="A11540R14">14</xref>). Miettinen et al. showed that Tizanidine can be regarded as an appropriate substitution for Clonidine during the operation because of its shorter duration of action (<xref ref-type="bibr" rid="A11540R15">15</xref>). In this study the average percentages of variation in blood pressure, including systolic and diastolic blood pressure and MAP, was below 20% of basal level in all the patients who were given Tizanidine which was mostly less than that of the patients in control group. In some members of control group, blood pressure variation up to 27% of the basal level was recorded (<xref ref-type="fig" rid="fig4734">Figures 1</xref>-<xref ref-type="fig" rid="fig4737">3</xref>). A few of the patients had increased blood pressure at 2 minutes after anesthesia induction. This finding may be justifiable by considering the innate differences in responding to the drugs of different individuals. Furthermore, the increase in blood pressure may be an aftereffect of pain caused by propofol infusion, or the anxiety before the surgery. Similarly, variation in heart rate was below 20% basal level in all patients given Tizanidine, whereas the variation of heart rate in all measurements in the control group was higher; even in some cases of control group the heart rate variation surpassed 20% of the basal level (<xref ref-type="fig" rid="fig4735">Figure 4</xref>). </p><fig id="fig4734" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Mean Systolic Blood Pressure Variation in the Two Groups</title></caption><graphic xlink:href="ircmj-15-541-i001"/></fig><fig id="fig4736" orientation="portrait" position="float"><label>Figure 2.</label><caption><title>Average of Mean Arterial Pressure Variation in the Two Groups</title></caption><graphic xlink:href="ircmj-15-541-i002"/></fig><fig id="fig4737" orientation="portrait" position="float"><label>Figure 3.</label><caption><title>The Mean Diastolic Blood Pressure Variation in the Two Groups</title></caption><graphic xlink:href="ircmj-15-541-i003"/></fig><fig id="fig4735" orientation="portrait" position="float"><label>Figure 4.</label><caption><title>The Mean Heart Rate Variation in the Two Groups</title></caption><graphic xlink:href="ircmj-15-541-i004"/></fig><p>Although the prescription of Clonidine was associated with severe decrease of blood pressure in cardiothoracic and non-cardiothoracic surgeries in several studies (<xref ref-type="bibr" rid="A11540R16">16</xref>), in our study neither severe hypotension( below 80 mmHg) nor sever bradycardia( below 50 beats/minute) resulted from Tizanidine use and the drug was tolerated with no considerable side-effect, the most common of which being mouth dryness. In addition, the effect of Tizanidine on required propofol dosage for anesthesia maintenance has been surveyed in this study. Average required Propofol dosage to maintain the anesthesia was 92.06 and 68.77 mcg/kg/min in control and case group respectively which showed a statistically significant difference (P &#x0003c; 0.001). In this survey, we found that applying Tizanidine as a premedication caused a 25% diminution in required Propofol for maintenance of anesthesia, which is comparable with previous studies on Clonidine with a reported 20% diminution (<xref ref-type="bibr" rid="A11540R17">17</xref>). In accordance to Jafarieh et al., there is not any significantly difference in variations of blood pressure and heart rate between the control group and the case group treated with Clonidine (<xref ref-type="bibr" rid="A11540R18">18</xref>).</p><p>Incident of postoperative shivering did not show any statistically significant difference between the two groups (P = 0.073); however, we did not find any synonymous studies that evaluated the effect of Tizanidine on postoperative shivering. Pier et al. investigation to compare the effect of Clonidine with Nefopam in preventing postoperative shivering proved that both Clonidine and Nefopam decrease the incidence and severity of postoperative shivering considerably in comparison to placebo, but the recovery time in Clonidine group was significantly more prolonged (<xref ref-type="bibr" rid="A11540R19">19</xref>). Butorphanol and Tramadol are more effective than Clonidine to inhibit the shivering, as suggested by Bansal et al. in a study aimed at comparing the effectiveness of these drugs on postoperative shivering (<xref ref-type="bibr" rid="A11540R20">20</xref>). Wajima et al. declared that prescribing 4 mg of oral Tizanidine 90 minutes prior to surgery lead to an 18% decline in minimum alveolar concentration (MAC) of Sevoflurane (<xref ref-type="bibr" rid="A11540R21">21</xref>). In a study on 60 patients undergoing coronary artery bypass graft (CABG) operation, Manjula et al. concluded that intravenous administration of 4mg Clonidine 30 minutes before the operation diminished the amount of drug required to induce anesthesia (<xref ref-type="bibr" rid="A11540R14">14</xref>). Considering this survey and other studies, it can be suggested that low dose (4 mg) of Tizanidine can establish hemodynamic stability. Additionally, it does not have side-effects such as a severe decrease in blood pressure seen in Clonidine. However, more investigations are needed to confirm that using Tizanidine along with lower doses of Propofol during the anesthesia is as safe as the higher doses of Propofol.</p><p>Given that cardiovascular status alteration in patients with coronary artery disease (CAD) can lead to dangerous and fatal consequences, we recommend more investigations be carried out to evaluate the effects of Tizanidine in these patients such as the effects of Tizanidine on patients&#x02019; recovery time. It is also suggested further studies be performed on effects of various doses of Tizanidine, regarding the effectiveness and cost-effective issues, in comparison with other drugs used to stabilize hemodynamic responses in stressful conditions of the operations (e.g. intubation and extubation of the airways). Prescription of oral Tizanidine as a premedication prior to the operations, in addition to sedative effects, causes stability in blood pressure and heart rate during the operations via decreasing central sympathetic activity. Regarding Tizanidine short duration of action, administration of this drug is recommended for sedating, stabilizing hemodynamic responses during the operations, and for reducing the required dose of anesthetic.</p></sec></body><back><ack><p>We want to acknowledge the Vice Chancellor of research, Mashhad university of medical sciences for the Financial and material support. We also thank Dr Hami Ashraf for his great work in writing assistance and Dr Habibollah Esmaieli for methodological and statistical consult. And last but not least, we know it is necessary to appreciate the great works of all the nurses and staffs of Ghaem hospital&#x02019;s central operation room for their close cooperation in this study.</p></ack><fn-group><fn id="afn13596" fn-type="other"><p>
<bold>Implication for health policy/practice/research/medical education:</bold>
</p><p>Prescription of oral Tizanidine as a premedication prior to the operations, in addition to sedative effects, causes stability in blood pressure and heart rate during the operations via decreasing central sympathetic activity in stressful conditions of the operations.</p></fn><fn id="afn13597" fn-type="other"><p>
<bold>Authors&#x02019; Contributions:</bold>
</p><p>Study concept and design: Dr Masoomeh Tabari, and Dr Mohammad Alipour. Analysis and interpretation of data: Dr Hamideh Esalati. Drafting of the manuscript: Dr Masoomeh Tabari and Dr Hamideh Esalati. Critical revision of the manuscript for important intellectual content: Dr Masoomeh Tabari, and Dr Mohammad Alipour. Statistical analysis: Dr Hamideh Esalati. Authors declared that they have no conflict of interest.</p></fn><fn id="afn13598" fn-type="financial-disclosure"><p>
<bold>Financial Disclosure:</bold>
</p><p>There is no financial disclosure.</p></fn><fn id="afn13599" fn-type="other"><p>
<bold>Funding Support:</bold>
</p><p>There is no funding or support.</p></fn></fn-group><ref-list><title>References</title><ref id="A11540R1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stoeltin</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>RD</given-names></name></person-group><source>Basics of Anesthesia.</source><year>2007</year><edition>5th ed</edition><publisher-loc>Churchill Livingstone</publisher-loc><publisher-name>Elsevier Health Sciences</publisher-name><isbn>9781437703658</isbn></element-citation></ref><ref id="A11540R2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>RL</given-names></name><name><surname>Marschall</surname><given-names>KE</given-names></name></person-group><source>Stoelting's Anesthesia and Co-Existing Disease.</source><year>2008</year><edition>5th ed</edition><publisher-name>Saunders</publisher-name><isbn>9781455700820</isbn></element-citation></ref><ref id="A11540R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momo</surname><given-names>K</given-names></name><name><surname>Homma</surname><given-names>M</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Kohda</surname><given-names>Y</given-names></name></person-group><article-title>[Clinical survey of tizanidine-induced adverse effects--impact of concomitant drugs providing cytochrome P450 1A2 modification--].</article-title><source>Yakugaku Zasshi.</source><year>2013</year><volume>133</volume><issue>2</issue><fpage>275</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">23370523</pub-id></element-citation></ref><ref id="A11540R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imanaga</surname><given-names>K</given-names></name><name><surname>Wajima</surname><given-names>Z</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>R</given-names></name></person-group><article-title>Effect of oral tizanidine on local-anesthetic infiltration pain during epidural catheterization.</article-title><source>J Nippon Med Sch.</source><year>2004</year><volume>71</volume><issue>2</issue><fpage>105</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15260084</pub-id></element-citation></ref><ref id="A11540R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijeysundera</surname><given-names>DN</given-names></name><name><surname>Naik</surname><given-names>JS</given-names></name><name><surname>Beattie</surname><given-names>WS</given-names></name></person-group><article-title>Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis.</article-title><source>Am J Med.</source><year>2003</year><volume>114</volume><issue>9</issue><fpage>742</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">12829201</pub-id></element-citation></ref><ref id="A11540R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crassous</surname><given-names>PA</given-names></name><name><surname>Denis</surname><given-names>C</given-names></name><name><surname>Paris</surname><given-names>H</given-names></name><name><surname>Senard</surname><given-names>JM</given-names></name></person-group><article-title>Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives.</article-title><source>Curr Top Med Chem.</source><year>2007</year><volume>7</volume><issue>2</issue><fpage>187</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">17266605</pub-id></element-citation></ref><ref id="A11540R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javaherforoosh</surname><given-names>F</given-names></name><name><surname>Pipelzadeh</surname><given-names>M</given-names></name><name><surname>Bagherybarma</surname><given-names>F</given-names></name></person-group><article-title>Comparison of Clonidin,Pethedin and Fentanyl for Post-spinal Anesthesia Shivering in Elective Caesarian Sections.</article-title><source>Armaghan Danesh, Yasuj Univ Med Res Scie J.</source><year>2006</year><volume>11</volume><issue>43</issue></element-citation></ref><ref id="A11540R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takenaka</surname><given-names>M</given-names></name><name><surname>Iida</surname><given-names>H</given-names></name><name><surname>Kasamatsu</surname><given-names>M</given-names></name><name><surname>Katoh</surname><given-names>H</given-names></name><name><surname>Tashiro</surname><given-names>T</given-names></name><name><surname>Dohi</surname><given-names>S</given-names></name></person-group><article-title>[Tizanidine for preanesthetic medication].</article-title><source>Masui.</source><year>1996</year><volume>45</volume><issue>8</issue><fpage>971</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8818094</pub-id></element-citation></ref><ref id="A11540R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelman</surname><given-names>E</given-names></name><name><surname>Lipszyc</surname><given-names>M</given-names></name><name><surname>Gilbart</surname><given-names>E</given-names></name><name><surname>Van der Linden</surname><given-names>P</given-names></name><name><surname>Bellens</surname><given-names>B</given-names></name><name><surname>Van Romphey</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Effects of clonidine on anesthetic drug requirements and hemodynamic response during aortic surgery.</article-title><source>Anesthesiology.</source><year>1989</year><volume>71</volume><issue>2</issue><fpage>178</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">2502935</pub-id></element-citation></ref><ref id="A11540R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasani</surname><given-names>VA</given-names></name><name><surname>Taheri</surname><given-names>FM</given-names></name><name><surname>Mehdizadeh</surname><given-names>A</given-names></name></person-group><article-title>The effect of oral clonidine premedication on hemodynamic responses during gynecologic laparascopy under general anesthesia.</article-title><source>Razi J Med Scie.</source><year>2006</year><volume>13</volume><issue>50</issue><fpage>39</fpage><lpage>46</lpage></element-citation></ref><ref id="A11540R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassani</surname><given-names>V</given-names></name></person-group><article-title>Clonidine decreases cardiovascular alterations during tracheal extubation.</article-title><source>Hakim.</source><year>2004</year><volume>6</volume><issue>4</issue><fpage>51</fpage><lpage>6</lpage></element-citation></ref><ref id="A11540R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabalameli</surname><given-names>M</given-names></name><name><surname>Hashemi</surname><given-names>SM</given-names></name><name><surname>Soltani</surname><given-names>HA</given-names></name><name><surname>Hashemi</surname><given-names>SJ</given-names></name></person-group><article-title>Oral clonidine premedication decreases intraoperative bleeding in patients undergoing endoscopic sinus surgery.</article-title><source>J Res Med Scie.</source><year>2005</year><volume>10</volume><issue>1</issue><fpage>25</fpage><lpage>30</lpage></element-citation></ref><ref id="A11540R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maze</surname><given-names>M</given-names></name><name><surname>Birch</surname><given-names>B</given-names></name><name><surname>Vickery</surname><given-names>RG</given-names></name></person-group><article-title>Clonidine reduces halothane MAC in rats.</article-title><source>Anesthesiology.</source><year>1987</year><volume>67</volume><issue>5</issue><fpage>868</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3674509</pub-id></element-citation></ref><ref id="A11540R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>MS</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>Effect of clonidine as an adjunct to induction agent in CABG patients.</article-title><source>Bombay Hosp J.</source><year>2010</year><volume>52</volume><issue>1</issue><fpage>25</fpage><lpage>9</lpage></element-citation></ref><ref id="A11540R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miettinen</surname><given-names>TJ</given-names></name><name><surname>Kanto</surname><given-names>JH</given-names></name><name><surname>Salonen</surname><given-names>MA</given-names></name><name><surname>Scheinin</surname><given-names>M</given-names></name></person-group><article-title>The sedative and sympatholytic effects of oral tizanidine in healthy volunteers.</article-title><source>Anesth Analg.</source><year>1996</year><volume>82</volume><issue>4</issue><fpage>817</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">8615503</pub-id></element-citation></ref><ref id="A11540R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henney</surname><given-names>HR, 3rd</given-names></name><name><surname>Chez</surname><given-names>M</given-names></name></person-group><article-title>Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.</article-title><source>Paediatr Drugs.</source><year>2009</year><volume>11</volume><issue>6</issue><fpage>397</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.2165/11316090-000000000-00000</pub-id><pub-id pub-id-type="pmid">19877725</pub-id></element-citation></ref><ref id="A11540R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>SB</given-names></name><name><surname>Zalunardo</surname><given-names>MP</given-names></name><name><surname>Seifert</surname><given-names>B</given-names></name><name><surname>Rentsch</surname><given-names>KM</given-names></name><name><surname>Rohling</surname><given-names>RG</given-names></name><name><surname>Pasch</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Clonidine decreases propofol requirements during anaesthesia: effect on bispectral index.</article-title><source>Br J Anaesth.</source><year>2001</year><volume>86</volume><issue>5</issue><fpage>627</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11575336</pub-id></element-citation></ref><ref id="A11540R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omote</surname><given-names>K</given-names></name><name><surname>Satoh</surname><given-names>O</given-names></name><name><surname>Sonoda</surname><given-names>H</given-names></name><name><surname>Kumeta</surname><given-names>Y</given-names></name><name><surname>Yamaya</surname><given-names>K</given-names></name><name><surname>Namiki</surname><given-names>A</given-names></name></person-group><article-title>[Effects of oral alpha 2 adrenergic agonists, clonidine and tizanidine, on tetracaine spinal anesthesia].</article-title><source>Masui.</source><year>1995</year><volume>44</volume><issue>6</issue><fpage>816</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">7637157</pub-id></element-citation></ref><ref id="A11540R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piper</surname><given-names>SN</given-names></name><name><surname>Suttner</surname><given-names>SW</given-names></name><name><surname>Schmidt</surname><given-names>CC</given-names></name><name><surname>Maleck</surname><given-names>WH</given-names></name><name><surname>Kumle</surname><given-names>B</given-names></name><name><surname>Boldt</surname><given-names>J</given-names></name></person-group><article-title>Nefopam and clonidine in the prevention of postanaesthetic shivering.</article-title><source>Anaesthesia.</source><year>1999</year><volume>54</volume><issue>7</issue><fpage>695</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10417466</pub-id></element-citation></ref><ref id="A11540R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>P</given-names></name><name><surname>Jain</surname><given-names>G</given-names></name></person-group><article-title>Control of shivering with clonidine, butorphanol, and tramadol under spinal anesthesia: a comparative study.</article-title><source>Local Reg Anesth.</source><year>2011</year><volume>4</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.2147/LRA.S15366</pub-id><pub-id pub-id-type="pmid">22915890</pub-id></element-citation></ref><ref id="A11540R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wajima</surname><given-names>Z</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Ogura</surname><given-names>A</given-names></name><name><surname>Imanaga</surname><given-names>K</given-names></name><name><surname>Shiga</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Oral tizanidine, an alpha2-adrenoceptor agonist, reduces the minimum alveolar concentration of sevoflurane in human adults.</article-title><source>Anesth Analg.</source><year>2002</year><volume>95</volume><issue>2</issue><fpage>393-6</fpage><pub-id pub-id-type="pmid">12145058</pub-id></element-citation></ref></ref-list></back></article>